An affibody which targets human epidermal growth factor receptor 2 (HER2)-expressing breast cancer lesions has been shown to allow early detection of HER2-positive pulmonary metastases and with more specificity than 18F-FDG, according to a study published online May 11 in the
Journal of Nuclear Medicine.
BC Technical has acquired Consus Medical Imaging, a Jacksonville, Fla.-based company that provides molecular imaging equipment service. While the company did not disclose the transaction amount, BC Technical said this acquisition will expand its customer base in the Southeast.
The most advanced biomarker research may move beyond diagnostic imaging, surgical planning and monitoring of drug therapies to include predictive medicine.
BC Technical has acquired RA Services, a Detroit-based company that services molecular imaging equipment. This acquisition will expand BC Technical's customer base in the Midwest.
An estimated 4 to 7 percent of nuclear and molecular imaging procedures are repeated due to poor imaging, which equates to $132 million in Medicare spending on avoidable scans, according to the Government Accountability Office. The Consistency, Accuracy, Responsibility and Excellence in Medical Imaging (CARE) bill, which would establish minimum education and certification standards for personnel who perform nuclear medicine and molecular imaging procedures, could help curb these costs, according to SNM.
A newly developed set of residency training pathways, crafted by an American College of Radiology (ACR)/Society of Nuclear Medicine (SNM) task force, integrates the complementary disciplines of diagnostic radiology (DR), nuclear radiology, nuclear medicine and molecular imaging, which are described in an article published in the April issue of the
Journal of the American College of Radiology.
Use of florbetaben, a PET tracer, to detect beta-amyloid plaques in the brain may help doctors diagnose Alzheimer’s disease (AD) earlier, according to research to be presented as part of the emerging science program at the American Academy of Neurology’s 64
th annual meeting in New Orleans, April 21-28.
Clino, a venture by Tohoku University in Sendai, Japan, has entered into a research collaboration with GE Healthcare’s medical diagnostics division to discover in vivo imaging tracers for tau proteins that accumulate in the brains of patients with Alzheimer’s disease.
Research has shown systemic inflammation causes an increase in depressive symptoms concurrent with changes in glucose metabolism in the parts of the brain responsible for mood and motivation, and the findings could lead to depression treatments for patients who have symptoms related to inflammation in the body or brain, according to a study published in the April issue of the
Journal of Nuclear Medicine.
GE Healthcare and Dyax have signed a licensing agreement for the development and commercialization of peptides binding to c-Met, which provides upfront, milestone and royalty payments to Dyax. The license includes application of the peptides in PET, SPECT and optical imaging.
The American College of Radiology (ACR) and Society of Nuclear Medicine convened a task force on combined training in diagnostic radiology, nuclear radiology, nuclear medicine and molecular imaging in May 2011, with the goal of developing realistic pathways to integrated residency training, and ACR recommends “expeditiously” moving forward with the design of integrated pathways, according to an article published online in January in the Journal of American College of Radiology.
The FDA has sent a letter to Cell>Point indicating agreement on a Special Protocol Assessment for the company's Phase III pivotal clinical study of technetium-99m-EC-G in lung cancer.
Researchers with the National Institutes of Health (NIH) have developed a method to label transplanted cells so they can be tracked by MRI, potentially offering a way to measure how many transplanted immune or stem cells reach their target during cell therapy.
The nuclear installations in Petten, The Netherlands, can withstand extreme conditions including flooding events and earthquakes, or a combination of both. This is shown by the results of an in-depth stress test that were sent by Minister Verhagen (The Netherlands Ministry of Economic Affairs, Agriculture and Innovation) to the Dutch Lower Chamber.
During the SNM [Society of Nuclear Medicine] House of Delegates meeting held Jan. 26-29 in Orlando, Fla., at the Mid-Winter meeting, the body approved a proposed amendment to the SNM bylaws that would change the name of the association to the “Society of Nuclear Medicine and Molecular Imaging.”
Two recently published PET studies reveal the ways in which molecular imaging can be used to treat difficult cases of breast cancer. The first deals with an imaging agent that targets estrogen receptors (ER) in ER-positive breast cancer patients with formerly inconclusive assessments, and the second highlights the ability of
18F-FDG to help predict the prognosis for patients undergoing chemotherapy for a very aggressive type of breast cancer. Both studies were published in the February issue of the
Journal of Nuclear Medicine.
Karolinska Institutet in Stockholm and AstraZeneca have formed a three-year collaborative research agreement that will apply molecular imaging technologies to generate new diagnostic imaging tools.
Bioscan, a developer of preclinical imaging systems, has established a subsidiary in Dijon, France, Bioscan Molecular Imaging France.
GE Healthcare has paid the U.S. $30 million, plus interest, to settle allegations that a company it acquired in 2004, Amersham Health, had violated the False Claims Act by causing Medicare to overpay for Myoview, a radiopharmaceutical used in certain cardiac diagnostic imaging procedures, according to the U.S. Department of Justice.
FDG uptake of thymus measured by PET/CT is an effective indicator for the differentiation of mediastinal lymphoma from normal thymus in pediatric patients, according to a study published online Dec. 12 in Radiology.
